Literature DB >> 8230643

Ethics consultants' recommendations for life-prolonging treatment of patients in a persistent vegetative state.

E Fox1, C Stocking.   

Abstract

OBJECTIVE--Surprisingly little is known about the content of ethics consultants' recommendations. We chose to study this issue using hypothetical persistent vegetative state (PVS) cases. We addressed four questions: What recommendations do ethics consultants give regarding life-prolonging treatment (LPT) in PVS cases? To what degree is there consensus? What factors influence recommendations? Do recommendations conform to established guidelines? DESIGN--Questionnaire survey. Our questionnaire asked subjects what they would recommend for seven hypothetical vignettes involving a PVS patient that varied with respect to advance directives and family wishes. We also questioned subjects about demographic characteristics, ethics consultation experience, and personal preference for LPT in PVS. SUBJECTS--Attendees at an annual meeting of the Society for Bioethics Consultation (n = 154). RESULTS--The response rate was 77%. Eighty-one percent of respondents were ethics committee members and 62% were ethics consultants. There was general agreement among respondents for only one of seven vignettes: in the case of a PVS patient whose advance directive and family agree that LPT be stopped, 93% recommended stopping all LPT. Responses to other vignettes varied considerably. Although patient wishes were an important factor influencing recommendations, none of the respondents adhered invariably to the patient's advance directive. Recommendations were also influenced by family wishes, resource allocation considerations, legal constraints, and personal preference for LPT in PVS. Guidelines we examined were generally too equivocal to be useful for evaluating ethics consultants' recommendations. CONCLUSIONS--The finding of wide variability in ethics consultants' recommendations suggests a need to clarify standards for ethics consultation.

Entities:  

Keywords:  Bioethics and Professional Ethics; Death and Euthanasia; Empirical Approach

Mesh:

Year:  1993        PMID: 8230643

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  10 in total

1.  Traversing boundaries: clinical ethics, moral experience, and the withdrawal of life supports.

Authors:  Mark J Bliton; Stuart G Finder
Journal:  Theor Med Bioeth       Date:  2002

2.  Withholding life prolonging treatment, and self deception.

Authors:  G M Sayers; S Perera
Journal:  J Med Ethics       Date:  2002-12       Impact factor: 2.903

3.  Should a medical/surgical specialist with formal training in bioethics provide health care ethics consultation in his/her own area of speciality?

Authors:  Mark Bernstein; Kerry Bowman
Journal:  HEC Forum       Date:  2003-09

4.  The case of Mr. Sims.

Authors:  J R Thobaben
Journal:  HEC Forum       Date:  1995 Mar-May

5.  Towards Substantive Standardization: Ethical Rules as Ethical Presumptions.

Authors:  Benjamin Chan
Journal:  HEC Forum       Date:  2016-06

6.  Clinical Ethics Consultants are not "Ethics" Experts-But They do Have Expertise.

Authors:  Lisa M Rasmussen
Journal:  J Med Philos       Date:  2016-06-14

7.  Survey of Japanese physicians' attitudes towards the care of adult patients in persistent vegetative state.

Authors:  A Asai; M Maekawa; I Akiguchi; T Fukui; Y Miura; N Tanabe; S Fukuhara
Journal:  J Med Ethics       Date:  1999-08       Impact factor: 2.903

8.  When previously expressed wishes conflict with best interests.

Authors:  Alexander K Smith; Bernard Lo; Rebecca Sudore
Journal:  JAMA Intern Med       Date:  2013-07-08       Impact factor: 21.873

9.  Clinical ethics consultation: examining how American and Japanese experts analyze an Alzheimer's case.

Authors:  Noriko Nagao; Mark P Aulisio; Yoshio Nukaga; Misao Fujita; Shinji Kosugi; Stuart Youngner; Akira Akabayashi
Journal:  BMC Med Ethics       Date:  2008-01-29       Impact factor: 2.652

10.  Comparison of ethical judgments exhibited by clients and ethics consultants in Japan.

Authors:  Noriko Nagao; Yasuhiro Kadooka; Atsushi Asai
Journal:  BMC Med Ethics       Date:  2014-03-04       Impact factor: 2.652

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.